The artificial pancreas — a device which monitors blood glucose in patients with type 1 diabetes and then automatically adjusts levels of insulin entering the body — is likely to be available by 2018, conclude authors of a paper in Diabetologia (the journal of the European Association for the Study of Diabetes). Issues such as speed of action of the forms of insulin used, reliability, convenience and accuracy of glucose monitors plus cybersecurity to protect devices from hacking, are among the issues that are being addressed.
Read more from Diabetologia at SpringerLink
The latest: Fourth Artificial Pancreas Workshop: Testing and Adoption of Current and Emerging Technologies July 6-7, 2016 Act Now
